Amlodipine Besylate/Valsartan

苯磺酸氨氯地平/缬沙坦

Report date: 2026/02/05 10:48:31

Base Information

Drug NameAmlodipine Besylate/Valsartan
Drug Alias Name苯磺酸氨氯地平缬沙坦Amlodipine Besylate-ValsartanAmlodipine Besilate/Valsartan缬沙坦苯磺酸氨氯地平Amlodipine Besylate and Valsartan +[13] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsEssential HypertensionHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryEU
Original Approved Date2007/01/15
Country/TerritoryUnited StatesSwedenTurkey +[16] 
CombinationsYes Amlodipine BesylateValsartan
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesINTERNATIONAL BIO SERVICES CO LTDZhejiang Hemukang Pharmaceutical Technology Co LtdNovartis Pharma Schweiz Ag +[5] 
Inactive CompaniesJiangxi Shimei Pharmaceutical Co Ltd
Active IndicationsEssential HypertensionHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DB01
Related LinksWikipediaKEGG